Autoimmunity Reviews , 8(8), 697701
J.LiY.HanY.ZhouD
In the multicenter, randomized, placebo-controlled Q-SYMBIO trial, a daily CoQ10 intake of 300mg was found to significantly reduce the incidence of a major adverse cardiovascular event in 15% of subjects (63 out of 420 participants),57 and a 2025 meta-analysis determined that long-term supplementation with doses as low as 100mg significantly reduced users systolic blood pressure.58 IM8 has perhaps too little CoQ10 to make a noticeable difference in, say, heart attack risk, but it seems well-dosed for people looking to alleviate hypertension
Route: Intravenous (IV) or Intramuscular (IM) as clinically appropriate
HRMC cells were cultivated in HG conditions, and HU effectively attenuated the HG-induced inflammation and apoptosis
Methycobals production is supported by WHO-GMP certification, which guarantees the products effectiveness